Cargando…

Electroconvulsive Therapy for Parkinson’s Disease with Depression and Neuroleptic Malignant Syndrome: A Case Report

Parkinson’s disease is often complicated by psychiatric symptoms. Psychiatrists are caught in a dilemma between such symptoms and physical treatment since Parkinson’s disease sometimes shows treatment resistance based on pharmacological treatment-induced dopamine dysfunction. Here, we report on a 64...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Yuhei, Miura, Itaru, Nozaki, Michinari, Osakabe, Yusuke, Izumi, Ryuta, Akama, Takahiro, Kimura, So, Yabe, Hirooki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316652/ https://www.ncbi.nlm.nih.gov/pubmed/34294629 http://dx.doi.org/10.9758/cpn.2021.19.3.572

Ejemplares similares

Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A case report
por: Osca Oliver, A., et al.
Publicado: (2023)

Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report
por: Ito, Masashi, et al.
Publicado: (2019)

Neuroleptic malignant syndrome: a case responding to electroconvulsive therapy plus bupropion
por: Foguet-Boreu, Quintí, et al.
Publicado: (2018)

Propofol-Remifentanil Combination for Management of Electroconvulsive Therapy in a Patient with Neuroleptic Malignant Syndrome
por: Arasteh, Modabber, et al.
Publicado: (2012)

Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report
por: Katzell, Lauren, et al.
Publicado: (2023)

The efficacy of antipsychotics for prolonged delirium with renal dysfunction
por: Asano, Satoko, et al.
Publicado: (2017)

COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia
por: Kaneko, Haruka, et al.
Publicado: (2018)

NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997)

Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016)

Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

Parkinson disease and Neuroleptic withdrawal
por: Jambunathan, Stephen, et al.
Publicado: (2010)

Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials
por: Miura, Itaru, et al.
Publicado: (2020)

Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report
por: Horikoshi, Sho, et al.
Publicado: (2017)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
por: Ichinose, Mizue, et al.
Publicado: (2021)

Neuroleptic‐induced Parkinsonism: Clinicopathological study
por: Shuaib, Umar A., et al.
Publicado: (2015)

Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report
por: Miura, Itaru, et al.
Publicado: (2014)

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)

Malignant Catatonia Versus Neuroleptic Malignant Syndrome
por: Desai, Saral, et al.
Publicado: (2021)

Risk Factors in Neuroleptic Malignant Syndrome
por: Gupta, Vinay, et al.
Publicado: (2003)

Resolution of symptoms in neuroleptic malignant syndrome
por: Pereira, Yvonne D.S., et al.
Publicado: (2010)

Olanzapine induced neuroleptic malignant syndrome
por: Patra, Bichitra Nanda, et al.
Publicado: (2013)

Olanzapine-Induced Neuroleptic Malignant Syndrome
por: Hosseini, Seyedhamze, et al.
Publicado: (2017)

Olanzapine-induced Neuroleptic Malignant Syndrome
por: Saha, Pradeep Kumar, et al.
Publicado: (2017)

Clozapine Induced Neuroleptic Malignant Syndrome
por: Jo, Yong Suk, et al.
Publicado: (2017)

Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021)

Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics
por: Grover, Sandeep, et al.
Publicado: (2012)

PM446. The relationship between MMN and COMT Val108/158Met genotype in schizophrenia
por: Horikoshi, Sho, et al.
Publicado: (2016)

Managing an effective treatment for neuroleptic malignant syndrome
por: Reulbach, Udo, et al.
Publicado: (2007)

RECOVERY AND RECHALLENGE AFTER THE NEUROLEPTIC MALIGNANT SYNOROME
por: Chopra, Mohit P., et al.
Publicado: (2001)

NEUROLEPTIC MALIGNANT SYNDROME - A CASE REPORT
por: De souza, Joaquim Victor, et al.
Publicado: (1986)

NEUROLEPTIC MALIGNANT SYNDROME : REPORT OF 2 CASES
por: Deshmukh, D.K., et al.
Publicado: (1989)

THE NEUROLEPTIC MALIGNANT SYNDROME : REPORT OF THREE CASES
por: Sharma, R.C., et al.
Publicado: (1996)

A case of recurrent neuroleptic malignant syndrome
por: Ouyang, Zexiang, et al.
Publicado: (2013)

Two unusual complications of neuroleptic malignant syndrome
por: Ahmad, A., et al.
Publicado: (2013)

Neuroleptic malignant syndrome: A diagnostic challenge
por: Ambulkar, Reshma P, et al.
Publicado: (2012)

Neuroleptic malignant syndrome in cycloserine-induced psychosis
por: Sawant, Neena S., et al.
Publicado: (2015)

Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent
por: Yıldırım, Veli, et al.
Publicado: (2017)

A Neuroleptic Malignant Syndrome Without Rigidity
por: Özdemir, İlker, et al.
Publicado: (2018)

A Case of Neuroleptic Malignant Syndrome in Pregnancy
por: Mittal, Maanvi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_86jirjj73896pu8fm8acgcrhc1